Table of Content

Table of Contents

Global Psoriasis Drugs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Psoriasis Drugs Market by Value
2.2.1 Global Psoriasis Drugs Revenue by Type
2.2.2 Global Psoriasis Drugs Market by Value (%)
2.3 Global Psoriasis Drugs Market by Production
2.3.1 Global Psoriasis Drugs Production by Type
2.3.2 Global Psoriasis Drugs Market by Production (%)

3. The Major Driver of Psoriasis Drugs Industry
3.1 Historical & Forecast Global Psoriasis Drugs Demand
3.2 Largest Application for Psoriasis Drugs (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Psoriasis Drugs Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Psoriasis Drugs Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Psoriasis Drugs Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Psoriasis Drugs Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Psoriasis Drugs Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Psoriasis Drugs Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Psoriasis Drugs Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Psoriasis Drugs Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Psoriasis Drugs Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Psoriasis Drugs Average Price Trend
12.1 Market Price for Each Type of Psoriasis Drugs in US (2018-2022)
12.2 Market Price for Each Type of Psoriasis Drugs in Europe (2018-2022)
12.3 Market Price for Each Type of Psoriasis Drugs in China (2018-2022)
12.4 Market Price for Each Type of Psoriasis Drugs in Japan (2018-2022)
12.5 Market Price for Each Type of Psoriasis Drugs in India (2018-2022)
12.6 Market Price for Each Type of Psoriasis Drugs in Korea (2018-2022)
12.7 Market Price for Each Type of Psoriasis Drugs in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Psoriasis Drugs Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Psoriasis Drugs

14. Psoriasis Drugs Competitive Landscape
14.1 Amgen
14.1.1 Amgen Company Profiles
14.1.2 Amgen Product Introduction
14.1.3 Amgen Psoriasis Drugs Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Eli Lilly
14.2.1 Eli Lilly Company Profiles
14.2.2 Eli Lilly Product Introduction
14.2.3 Eli Lilly Psoriasis Drugs Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Novartis
14.3.1 Novartis Company Profiles
14.3.2 Novartis Product Introduction
14.3.3 Novartis Psoriasis Drugs Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Merck
14.4.1 Merck Company Profiles
14.4.2 Merck Product Introduction
14.4.3 Merck Psoriasis Drugs Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Johnson & Johnson
14.5.1 Johnson & Johnson Company Profiles
14.5.2 Johnson & Johnson Product Introduction
14.5.3 Johnson & Johnson Psoriasis Drugs Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Pfizer
14.6.1 Pfizer Company Profiles
14.6.2 Pfizer Product Introduction
14.6.3 Pfizer Psoriasis Drugs Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 AstraZeneca
14.7.1 AstraZeneca Company Profiles
14.7.2 AstraZeneca Product Introduction
14.7.3 AstraZeneca Psoriasis Drugs Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 AbbVie
14.8.1 AbbVie Company Profiles
14.8.2 AbbVie Product Introduction
14.8.3 AbbVie Psoriasis Drugs Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 LEO Pharma
14.9.1 LEO Pharma Company Profiles
14.9.2 LEO Pharma Product Introduction
14.9.3 LEO Pharma Psoriasis Drugs Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Biogen
14.10.1 Biogen Company Profiles
14.10.2 Biogen Product Introduction
14.10.3 Biogen Psoriasis Drugs Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Psoriasis Drugs Industry (Volume)
Figure 2. Psoriasis Drugs Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Psoriasis Drugs Revenue in 2022
Figure 5. US Psoriasis Drugs Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Psoriasis Drugs Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Psoriasis Drugs Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Psoriasis Drugs Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Psoriasis Drugs Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Psoriasis Drugs Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Psoriasis Drugs Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Psoriasis Drugs Revenue, by Type (Million USD) (2018-2028)
Table 4. Psoriasis Drugs Production, by Type (K Unit) (2018-2028)
Table 5. Psoriasis Drugs Demand (K Unit) by Application (2018-2028)
Table 6. Psoriasis Drugs Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Psoriasis Drugs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Psoriasis Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Psoriasis Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Psoriasis Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Psoriasis Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Psoriasis Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Psoriasis Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Psoriasis Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Psoriasis Drugs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Psoriasis Drugs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Psoriasis Drugs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Psoriasis Drugs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Psoriasis Drugs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Psoriasis Drugs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Psoriasis Drugs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Amgen Profiles
Table 61. Amgen Psoriasis Drugs Product Introduction
Table 62. Amgen Psoriasis Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Amgen Strategic initiatives
Table 64. Eli Lilly Profiles
Table 65. Eli Lilly Psoriasis Drugs Product Introduction
Table 66. Eli Lilly Psoriasis Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Eli Lilly Strategic initiatives
Table 68. Novartis Profiles
Table 69. Novartis Psoriasis Drugs Product Introduction
Table 70. Novartis Psoriasis Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Novartis Strategic initiatives
Table 72. Merck Profiles
Table 73. Merck Psoriasis Drugs Product Introduction
Table 74. Merck Psoriasis Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Merck Strategic initiatives
Table 76. Johnson & Johnson Profiles
Table 77. Johnson & Johnson Psoriasis Drugs Product Introduction
Table 78. Johnson & Johnson Psoriasis Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Johnson & Johnson Strategic initiatives
Table 80. Pfizer Profiles
Table 81. Pfizer Psoriasis Drugs Product Introduction
Table 82. Pfizer Psoriasis Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Pfizer Strategic initiatives
Table 84. AstraZeneca Profiles
Table 85. AstraZeneca Psoriasis Drugs Product Introduction
Table 86. AstraZeneca Psoriasis Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. AstraZeneca Strategic initiatives
Table 88. AbbVie Profiles
Table 89. AbbVie Psoriasis Drugs Product Introduction
Table 90. AbbVie Psoriasis Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. AbbVie Strategic initiatives
Table 92. LEO Pharma Profiles
Table 93. LEO Pharma Psoriasis Drugs Product Introduction
Table 94. LEO Pharma Psoriasis Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. LEO Pharma Strategic initiatives
Table 97. Biogen Profiles
Table 98. Biogen Psoriasis Drugs Product Introduction
Table 99. Biogen Psoriasis Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Biogen Strategic initiatives